LEO LUZNIK to Proto-Oncogene Proteins c-bcl-6
This is a "connection" page, showing publications LEO LUZNIK has written about Proto-Oncogene Proteins c-bcl-6.
Connection Strength
0.195
-
Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease. Blood. 2019 01 03; 133(1):94-99.
Score: 0.161
-
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. Blood. 2016 04 28; 127(17):2144-54.
Score: 0.034